CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (CHUV)

In News

Virtual health threats trigger real immune response - healthcare-in-europe.com

healthcare-in-europe.com - Aug 18, 2025

CERN, CHUV and THERYQ join forces for a world first in cancer radiotherapy – Home - Home | CERN

Home | CERN - Nov 25, 2022

Raysearch Signs Agreements with Switzerland Clinics - Imaging Technology News

Imaging Technology News - Jun 28, 2021

CHUV, CERN and THERYQ partner to develop cancer radiotherapy device - Medical Device Network

Medical Device Network - Nov 28, 2022

Healiva® Announces Strategic Collaboration With Lausanne University Hospital to Manufacture EpiDex® for Severe Chronic Wound Treatment - Business Wire

Business Wire - Sep 26, 2023

Regulatory T cell therapy for xenotransplantation, what perspectives? - Frontiers

Frontiers - Sep 01, 2025

Onward reports more successful BCI implants - MassDevice

MassDevice - May 21, 2025

Cell therapy weekly: Phase III results for BrainStorm Cell Therapeutics’ ALS therapy lead to rejection by FDA committee - RegMedNet

RegMedNet - Sep 28, 2023

Defining the Quantitative Future of SPECT/CT - Siemens Healthineers

Siemens Healthineers - Nov 20, 2018

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma - Nature

Nature - Apr 30, 2024

Onward announces first-in-human implant of ARC-IM stimulator with wireless BCI device - NeuroNews International

NeuroNews International - Sep 27, 2023

World’s largest particle physics laboratory backs push to transform cancer radiotherapy - MedTech Dive

MedTech Dive - Nov 29, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment